BTK and Burkitt lymphoma: Furthermore, our study sought to explore the potential synergistic effects of combining these therapies with Ibrutinib, a widely used Bruton’s tyrosine kinase (BTK) inhibitor in Burkitt’s lymphoma treatment (13, 14).